Sutro Biopharma, Inc.
STRO
$30.52
$0.973.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 17.70% | 17.76% | -394.45% | 84.86% | -4.87% |
| Total Depreciation and Amortization | -21.31% | -14.53% | 0.00% | 0.00% | 1.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.22% | 15.72% | -21.59% | 0.82% | 5.21% |
| Change in Net Operating Assets | -462.09% | 0.65% | 109.19% | -453.04% | 41.87% |
| Cash from Operations | -59.86% | 30.78% | 14.61% | 34.12% | 5.37% |
| Capital Expenditure | 94.02% | 26.69% | -191.86% | 92.67% | -9.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -339.61% | -53.07% | 1,409.38% | 117.67% | -117.03% |
| Cash from Investing | -342.03% | -53.23% | 1,449.96% | 115.87% | -118.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,441,066.67% | -97.64% | -- | -100.00% | -- |
| Repurchase of Common Stock | -138.81% | -168.00% | 58.33% | 66.67% | -650.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 161,154.69% | -162.75% | 270.00% | -190.91% | 375.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 299.46% | -509.94% | 104.51% | 49.80% | -634.62% |